ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,235.48
-0.60%
US Tech 100
18,017.60
-1.31%
Dow Jones
38,111.48
-0.86%
Brent Oil
81.765
-0.23%
Bitcoin
68,293.19
-0.10%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/31/20241:31AMAlliance NewsAlliance NewsGET READY: CMO Group and JD Sports full-year results at 0700 BST
05/31/20241:30AMAlliance NewsAlliance NewsAlliance News UK - start of day
05/31/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
05/31/20241:30AMGlobeNewswire Inc.Nicox annonce l’organisation d’un webcast pour ses actionnaires le 6 juin 2024 à 18h00 CET à l’occasion de son augmentation du capital déjà en coursEU:ALCOXNicox SA
05/31/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
05/31/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
05/31/20241:30AMGlobeNewswire Inc.Nicox annonce l’organisation d’un webcast pour ses actionnaires le 6 juin 2024 à 18h00 CET à l’occasion de son augmentation du capital déjà en coursLSE:0RCQNicox Sa
05/31/20241:30AMGlobeNewswire Inc.Nicox annonce l’organisation d’un webcast pour ses actionnaires le 6 juin 2024 à 18h00 CET à l’occasion de son augmentation du capital déjà en coursTG:NXOANicox SA
05/31/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
05/31/20241:30AMGlobeNewswire Inc.Baosheng Media Group Holdings Limited Announces Filing of Current Report on Form 6-K with the SEC regarding Pending Legal ProceedingNASDAQ:BAOSBaosheng Media Group Holdings Ltd
05/31/20241:17AMPR Newswire (US)MoonFox Analysis | How WeChat Channels Burdens of Tencent's Hopes for the Future Amidst Rapid CommercializationNASDAQ:JGAurora Mobile Ltd
05/31/20241:07AMAlliance NewsAlliance NewsJapan's monthly retail sales rebound in April; unemployment stable
05/31/20241:05AMGlobeNewswire Inc.Communiqué de presse : Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCOBIT:1SANSanofi
05/31/20241:05AMGlobeNewswire Inc.Net asset value of the EfTEN United Property Fund as of 30.04.2024
05/31/20241:05AMGlobeNewswire Inc.Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPDBIT:SANFSanofi
05/31/20241:05AMGlobeNewswire Inc.Communiqué de presse : Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCOEU:SANSanofi
05/31/20241:05AMGlobeNewswire Inc.Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPDEU:SANSanofi
05/31/20241:05AMGlobeNewswire Inc.Communiqué de presse : Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCOBIT:SANFSanofi
05/31/20241:05AMGlobeNewswire Inc.Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPDBIT:1SANSanofi
05/31/20241:05AMGlobeNewswire Inc.Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPDEU:SANSanofi
05/31/20241:05AMGlobeNewswire Inc.Communiqué de presse : Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCOTG:SNWSanofi
05/31/20241:05AMGlobeNewswire Inc.Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPDTG:SNWSanofi
05/31/20241:05AMGlobeNewswire Inc.Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPDNASDAQ:REGNRegeneron Pharmaceuticals Inc
05/31/20241:05AMGlobeNewswire Inc.Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPDEU:SANSanofi
05/31/20241:05AMGlobeNewswire Inc.Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPDNASDAQ:SNYSanofi
05/31/20241:00AMGlobeNewswire Inc.VEON discloses April YTD trading update at its AGMEU:VEONVEON Ltd
05/31/20241:00AMBusiness WireElliptic Labs Launching on Upcoming vivo S19 and S19 Pro Smartphones
05/31/20241:00AMGlobeNewswire Inc.Issue of Additional Tier 1 Temporary Write-Down Notes
05/31/20241:00AMGlobeNewswire Inc.VEON discloses April YTD trading update at its AGMLSE:0RO7Veon Ltd
05/31/20241:00AMGlobeNewswire Inc.Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024NASDAQ:ADXNAddex Therapeutics Ltd

Your Recent History

USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
KEGS
1812 Brewing (PK)
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
ASKH
Astika (PK)
USOTC
SPZI
Spooz (PK)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
GRLT
Grillit (PK)
NASDAQ
AGBA
AGBA
USOTC
TDRK
TideRock Companies (PK)
NASDAQ
IOVA
Iovance Biotherapeutics
USOTC
NSAV
Net Savings Link (PK)
USOTC
AFFU
Affluence (PK)
USOTC
HHSE
Hannover House (PK)
USOTC
CYDY
CytoDyn (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved